Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 102

1.

Treatment with Botulinum Neurotoxin Improves Activities of Daily Living and Quality of Life in Patients with Upper Limb Tremor.

Kreisler A, Bouchain B, Defebvre L, Krystkowiak P.

Tremor Other Hyperkinet Mov (N Y). 2019 Jul 26;9. doi: 10.7916/tohm.v0.640. eCollection 2019.

2.

Suggestive association between OPRM1 and impulse control disorders in Parkinson's disease.

Cormier-Dequaire F, Bekadar S, Anheim M, Lebbah S, Pelissolo A, Krack P, Lacomblez L, Lhommée E, Castrioto A, Azulay JP, Defebvre L, Kreisler A, Durif F, Marques-Raquel A, Brefel-Courbon C, Grabli D, Roze E, Llorca PM, Ory-Magne F, Benatru I, Ansquer S, Maltête D, Tir M, Krystkowiak P, Tranchant C, Lagha-Boukbiza O, Lebrun-Vignes B, Mangone G, Vidailhet M, Charbonnier-Beaupel F, Rascol O, Lesage S, Brice A, Tezenas du Montcel S, Corvol JC; BADGE-PD study group.

Mov Disord. 2018 Dec;33(12):1878-1886. doi: 10.1002/mds.27519. Epub 2018 Nov 16.

PMID:
30444952
3.

Acute Dementia After Deep Brain Stimulation in Parkinson Disease.

Puy L, Tir M, Lefranc M, Yaïche H, Godefroy O, Krystkowiak P.

World Neurosurg. 2018 Nov;119:63-65. doi: 10.1016/j.wneu.2018.07.197. Epub 2018 Jul 31.

PMID:
30075264
4.

Predicting Current Thresholds for Pyramidal Tract Activation Using Volume of Activated Tissue Modeling in Patients Undergoing Deep Brain Stimulation Surgery.

Bunaux K, Tir M, Constans JM, Macron JM, Krystkowiak P, Lefranc M.

World Neurosurg. 2018 Sep;117:e692-e697. doi: 10.1016/j.wneu.2018.06.112. Epub 2018 Jun 23.

PMID:
29945003
5.

Anxiety-dependent modulation of motor responses to pain expectancy.

Fossataro C, Bucchioni G, D'Agata F, Bruno V, Morese R, Krystkowiak P, Garbarini F.

Soc Cogn Affect Neurosci. 2018 Mar 1;13(3):321-330. doi: 10.1093/scan/nsx146.

6.

Mental Simulation of Painful Situations Has an Impact on Posture and Psychophysiological Parameters.

Lelard T, Godefroy O, Ahmaidi S, Krystkowiak P, Mouras H.

Front Psychol. 2017 Nov 21;8:2012. doi: 10.3389/fpsyg.2017.02012. eCollection 2017.

7.

Brain calcifications and PCDH12 variants.

Nicolas G, Sanchez-Contreras M, Ramos EM, Lemos RR, Ferreira J, Moura D, Sobrido MJ, Richard AC, Lopez AR, Legati A, Deleuze JF, Boland A, Quenez O, Krystkowiak P, Favrole P, Geschwind DH, Aran A, Segel R, Levy-Lahad E, Dickson DW, Coppola G, Rademakers R, de Oliveira JRM.

Neurol Genet. 2017 Jul 26;3(4):e166. doi: 10.1212/NXG.0000000000000166. eCollection 2017 Aug.

8.

Asleep Robot-Assisted Surgery for the Implantation of Subthalamic Electrodes Provides the Same Clinical Improvement and Therapeutic Window as Awake Surgery.

Lefranc M, Zouitina Y, Tir M, Merle P, Ouendo M, Constans JM, Godefroy O, Peltier J, Krystkowiak P.

World Neurosurg. 2017 Oct;106:602-608. doi: 10.1016/j.wneu.2017.07.047. Epub 2017 Jul 19.

PMID:
28735132
9.

Association Between Motor Symptoms and Brain Metabolism in Early Huntington Disease.

Gaura V, Lavisse S, Payoux P, Goldman S, Verny C, Krystkowiak P, Damier P, Supiot F, Bachoud-Levi AC, Remy P.

JAMA Neurol. 2017 Sep 1;74(9):1088-1096. doi: 10.1001/jamaneurol.2017.1200.

10.

Descriptive study of the parkinsonian population in the north of France: Epidemiological analysis and healthcare consumption.

Carriere N, Verloop D, Dupont C, Fontaine V, Tir M, Krystkowiak P, Blanchard A, Defebvre MM, Defebvre L.

Rev Neurol (Paris). 2017 Jun;173(6):396-405. doi: 10.1016/j.neurol.2017.03.036. Epub 2017 May 8.

PMID:
28495231
11.

A randomized, double-blind, placebo-controlled trial evaluating cysteamine in Huntington's disease.

Verny C, Bachoud-Lévi AC, Durr A, Goizet C, Azulay JP, Simonin C, Tranchant C, Calvas F, Krystkowiak P, Charles P, Youssov K, Scherer C, Prundean A, Olivier A, Reynier P, Saudou F, Maison P, Allain P, von Studnitz E, Bonneau D; CYST-HD Study Group.

Mov Disord. 2017 Jun;32(6):932-936. doi: 10.1002/mds.27010. Epub 2017 Apr 24.

PMID:
28436572
12.

Does impaired socioemotional functioning account for behavioral dysexecutive disorders? Evidence from a transnosological study.

Narme P, Roussel M, Mouras H, Krystkowiak P, Godefroy O.

Neuropsychol Dev Cogn B Aging Neuropsychol Cogn. 2017 Jan;24(1):80-93. Epub 2016 Apr 7.

PMID:
27054957
13.

Insulin-Like Growth Factor-1 but Not Insulin Predicts Cognitive Decline in Huntington's Disease.

Salem L, Saleh N, Désaméricq G, Youssov K, Dolbeau G, Cleret L, Bourhis ML, Azulay JP, Krystkowiak P, Verny C, Morin F, Moutereau S; French Huntington Study Group, Bachoud-Lévi AC, Maison P.

PLoS One. 2016 Sep 14;11(9):e0162890. doi: 10.1371/journal.pone.0162890. eCollection 2016.

14.

Dysexecutive syndrome in Parkinson's disease: the GREFEX study.

Roussel M, Lhommée E, Narme P, Czernecki V, Gall DL, Krystkowiak P, Diouf M, Godefroy O; GREFEX study group.

Neuropsychol Dev Cogn B Aging Neuropsychol Cogn. 2017 Sep;24(5):496-507. doi: 10.1080/13825585.2016.1226248. Epub 2016 Sep 1.

PMID:
27585478
15.

Movement disorders and stroke.

Defebvre L, Krystkowiak P.

Rev Neurol (Paris). 2016 Aug - Sep;172(8-9):483-487. doi: 10.1016/j.neurol.2016.07.006. Epub 2016 Jul 28. Review.

PMID:
27476417
16.

Huntington's Disease Revealed by Familial Cervical Dystonia.

Andriuta D, Tir M, Godefroy O, Krystkowiak P.

Mov Disord Clin Pract. 2016 Jan 18;3(4):415-416. doi: 10.1002/mdc3.12311. eCollection 2016 Jul-Aug. No abstract available.

17.

How to Capitalize on the Retest Effect in Future Trials on Huntington's Disease.

Schramm C, Katsahian S, Youssov K, Démonet JF, Krystkowiak P, Supiot F, Verny C, Cleret de Langavant L, Bachoud-Lévi AC; European Huntington's Disease Initiative Study Group and the Multicentre Intracerebral Grafting in Huntington's Disease Group.

PLoS One. 2015 Dec 29;10(12):e0145842. doi: 10.1371/journal.pone.0145842. eCollection 2015.

18.

Do we feel the same empathy for loved and hated peers?

Bucchioni G, Lelard T, Ahmaidi S, Godefroy O, Krystkowiak P, Mouras H.

PLoS One. 2015 May 29;10(5):e0125871. doi: 10.1371/journal.pone.0125871. eCollection 2015.

19.

Longitudinal study of informed consent in innovative therapy research: experience and provisional recommendations from a multicenter trial of intracerebral grafting.

Cleret de Langavant L, Sudraud S, Verny C, Krystkowiak P, Simonin C, Damier P, Demonet JF, Supiot F, Rialland A, Schmitz D, Maison P, Youssov K, Bachoud-Lévi AC.

PLoS One. 2015 May 26;10(5):e0128209. doi: 10.1371/journal.pone.0128209. eCollection 2015.

20.

Freezing behavior as a response to sexual visual stimuli as demonstrated by posturography.

Mouras H, Lelard T, Ahmaidi S, Godefroy O, Krystkowiak P.

PLoS One. 2015 May 20;10(5):e0127097. doi: 10.1371/journal.pone.0127097. eCollection 2015.

21.

Hedonic deficits in Parkinson's disease: is consummatory anhedonia specific?

Loas G, Duru C, Godefroy O, Krystkowiak P.

Front Neurol. 2014 Mar 10;5:24. doi: 10.3389/fneur.2014.00024. eCollection 2014.

22.

Influence of postural threat on postural responses to aversive visual stimuli.

Lelard T, Krystkowiak P, Montalan B, Longin E, Bucchioni G, Ahmaidi S, Godefroy O, Mouras H.

Behav Brain Res. 2014 Jun 1;266:137-45. doi: 10.1016/j.bbr.2014.02.051. Epub 2014 Mar 12.

PMID:
24631393
23.

High-resolution 3-dimensional T2*-weighted angiography (HR 3-D SWAN): an optimized 3-T magnetic resonance imaging sequence for targeting the subthalamic nucleus.

Lefranc M, Derrey S, Merle P, Tir M, Constans JM, Montpellier D, Macron JM, Le Gars D, Peltier J, Baledentt O, Krystkowiak P.

Neurosurgery. 2014 Jun;74(6):615-26; discussion 627. doi: 10.1227/NEU.0000000000000319.

PMID:
24535261
24.

Targeting the red nucleus for cerebellar tremor.

Lefranc M, Manto M, Merle P, Tir M, Montpellier D, Constant JM, Le Gars D, Macron JM, Krystkowiak P.

Cerebellum. 2014 Jun;13(3):372-7. doi: 10.1007/s12311-013-0546-z.

PMID:
24415178
25.

Rivastigmine in apathetic but dementia and depression-free patients with Parkinson's disease: a double-blind, placebo-controlled, randomised clinical trial.

Devos D, Moreau C, Maltête D, Lefaucheur R, Kreisler A, Eusebio A, Defer G, Ouk T, Azulay JP, Krystkowiak P, Witjas T, Delliaux M, Destée A, Duhamel A, Bordet R, Defebvre L, Dujardin K.

J Neurol Neurosurg Psychiatry. 2014 Jun;85(6):668-74. doi: 10.1136/jnnp-2013-306439. Epub 2013 Nov 11.

PMID:
24218528
26.

Phenotypic spectrum of probable and genetically-confirmed idiopathic basal ganglia calcification.

Nicolas G, Pottier C, Charbonnier C, Guyant-Maréchal L, Le Ber I, Pariente J, Labauge P, Ayrignac X, Defebvre L, Maltête D, Martinaud O, Lefaucheur R, Guillin O, Wallon D, Chaumette B, Rondepierre P, Derache N, Fromager G, Schaeffer S, Krystkowiak P, Verny C, Jurici S, Sauvée M, Vérin M, Lebouvier T, Rouaud O, Thauvin-Robinet C, Rousseau S, Rovelet-Lecrux A, Frebourg T, Campion D, Hannequin D; French IBGC Study Group.

Brain. 2013 Nov;136(Pt 11):3395-407. doi: 10.1093/brain/awt255. Epub 2013 Sep 24.

PMID:
24065723
27.

Association between caffeine intake and age at onset in Huntington's disease.

Simonin C, Duru C, Salleron J, Hincker P, Charles P, Delval A, Youssov K, Burnouf S, Azulay JP, Verny C, Scherer C, Tranchant C, Goizet C, Debruxelles S, Defebvre L, Sablonnière B, Romon-Rousseaux M, Buée L, Destée A, Godefroy O, Dürr A, Landwehrmeyer B; REGISTRY Study of the European Huntington's Disease Network, Bachoud-Levi AC, Richard F, Blum D, Krystkowiak P; Huntington French Speaking Network.

Neurobiol Dis. 2013 Oct;58:179-82. doi: 10.1016/j.nbd.2013.05.013. Epub 2013 May 31.

PMID:
23732677
28.

Emotional and cognitive social processes are impaired in Parkinson's disease and are related to behavioral disorders.

Narme P, Mouras H, Roussel M, Duru C, Krystkowiak P, Godefroy O.

Neuropsychology. 2013 Mar;27(2):182-92. doi: 10.1037/a0031522.

PMID:
23527646
29.

Postural correlates with painful situations.

Lelard T, Montalan B, Morel MF, Krystkowiak P, Ahmaidi S, Godefroy O, Mouras H.

Front Hum Neurosci. 2013 Feb 5;7:4. doi: 10.3389/fnhum.2013.00004. eCollection 2013.

30.

Mutation of the PDGFRB gene as a cause of idiopathic basal ganglia calcification.

Nicolas G, Pottier C, Maltête D, Coutant S, Rovelet-Lecrux A, Legallic S, Rousseau S, Vaschalde Y, Guyant-Maréchal L, Augustin J, Martinaud O, Defebvre L, Krystkowiak P, Pariente J, Clanet M, Labauge P, Ayrignac X, Lefaucheur R, Le Ber I, Frébourg T, Hannequin D, Campion D.

Neurology. 2013 Jan 8;80(2):181-7. doi: 10.1212/WNL.0b013e31827ccf34. Epub 2012 Dec 19.

PMID:
23255827
31.

Anhedonia in Parkinson's disease: an overview.

Loas G, Krystkowiak P, Godefroy O.

J Neuropsychiatry Clin Neurosci. 2012 Fall;24(4):444-51. doi: 10.1176/appi.neuropsych.11110332. Review.

PMID:
23224450
32.

pH as a biomarker of neurodegeneration in Huntington's disease: a translational rodent-human MRS study.

Chaumeil MM, Valette J, Baligand C, Brouillet E, Hantraye P, Bloch G, Gaura V, Rialland A, Krystkowiak P, Verny C, Damier P, Remy P, Bachoud-Levi AC, Carlier P, Lebon V.

J Cereb Blood Flow Metab. 2012 May;32(5):771-9. doi: 10.1038/jcbfm.2012.15. Epub 2012 Feb 29.

33.

Suicide without depression after withdrawal of a dopamine agonist in a patient with Parkinson's disease.

Flament M, Loas G, Godefroy O, Krystkowiak P.

J Neuropsychiatry Clin Neurosci. 2011 Fall;23(4):E32. doi: 10.1176/jnp.23.4.jnpe32. No abstract available.

PMID:
22231340
34.

Are gait initiation parameters early markers of Huntington's disease in pre-manifest mutation carriers?

Delval A, Bleuse S, Simonin C, Delliaux M, Rolland B, Destee A, Defebvre L, Krystkowiak P, Dujardin K.

Gait Posture. 2011 Jun;34(2):202-7. doi: 10.1016/j.gaitpost.2011.04.011. Epub 2011 May 25.

PMID:
21616667
35.

Screening of the THAP1 gene in patients with early-onset dystonia: myoclonic jerks are part of the dystonia 6 phenotype.

Clot F, Grabli D, Burbaud P, Aya M, Derkinderen P, Defebvre L, Damier P, Krystkowiak P, Pollak P, Leguern E, San C, Camuzat A, Roze E, Vidailhet M, Durr A, Brice A.

Neurogenetics. 2011 Feb;12(1):87-9. doi: 10.1007/s10048-010-0264-3. Epub 2010 Nov 26. No abstract available.

PMID:
21110056
36.

External globus pallidus stimulation modulates brain connectivity in Huntington's disease.

Ligot N, Krystkowiak P, Simonin C, Goldman S, Peigneux P, Van Naemen J, Monclus M, Lacroix SF, Devos D, Dujardin K, Delmaire C, Bardinet E, Delval A, Delliaux M, Defebvre L, Yelnik J, Blond S, Destée A, De Tiège X.

J Cereb Blood Flow Metab. 2011 Jan;31(1):41-6. doi: 10.1038/jcbfm.2010.186. Epub 2010 Oct 20.

37.

[Persistent neurological disturbances].

Boone M, Sini V, Dupuy D, Le Page L, Godefroy O, Krystkowiak P.

Rev Med Interne. 2010 Sep;31(9):643-4. doi: 10.1016/j.revmed.2009.12.014. Epub 2010 Jul 31. French. No abstract available.

PMID:
20674101
38.

Psychomotor slowing in mild cognitive impairment, Alzheimer's disease and lewy body dementia: mechanisms and diagnostic value.

Bailon O, Roussel M, Boucart M, Krystkowiak P, Godefroy O.

Dement Geriatr Cogn Disord. 2010;29(5):388-96. doi: 10.1159/000305095. Epub 2010 May 20.

PMID:
20484908
39.

[The UHDRS scale].

Simonin C, Delliaux M, Krystkowiak P.

Rev Neurol (Paris). 2009 Sep;165 Spec No 3:F179-87. Review. French. No abstract available.

PMID:
20222181
40.
41.

[Long-term effects of botulinum toxin treatment].

Krystkowiak P.

Ann Dermatol Venereol. 2009 May;136 Suppl 4:S86-8. doi: 10.1016/S0151-9638(09)74533-8. Review. French.

PMID:
19576491
42.

[Hemifacial spasm].

Krystkowiak P.

Ann Dermatol Venereol. 2009 May;136 Suppl 4:S142-5. doi: 10.1016/S0151-9638(09)74542-9. French.

PMID:
19576481
43.

[Locomotion disturbances in Huntington's disease].

Delval A, Krystkowiak P.

Rev Neurol (Paris). 2010 Feb;166(2):213-20. doi: 10.1016/j.neurol.2009.05.013. Epub 2009 Jul 14. Review. French.

PMID:
19604530
44.

A genetic variation in the ADORA2A gene modifies age at onset in Huntington's disease.

Dhaenens CM, Burnouf S, Simonin C, Van Brussel E, Duhamel A, Defebvre L, Duru C, Vuillaume I, Cazeneuve C, Charles P, Maison P, Debruxelles S, Verny C, Gervais H, Azulay JP, Tranchant C, Bachoud-Levi AC, Dürr A, Buée L, Krystkowiak P, Sablonnière B, Blum D; Huntington French Speaking Network.

Neurobiol Dis. 2009 Sep;35(3):474-6. doi: 10.1016/j.nbd.2009.06.009. Epub 2009 Jul 8.

PMID:
19591938
45.

Bilateral pallidal deep brain stimulation for the treatment of patients with dystonia-choreoathetosis cerebral palsy: a prospective pilot study.

Vidailhet M, Yelnik J, Lagrange C, Fraix V, Grabli D, Thobois S, Burbaud P, Welter ML, Xie-Brustolin J, Braga MC, Ardouin C, Czernecki V, Klinger H, Chabardes S, Seigneuret E, Mertens P, Cuny E, Navarro S, Cornu P, Benabid AL, Le Bas JF, Dormont D, Hermier M, Dujardin K, Blond S, Krystkowiak P, Destée A, Bardinet E, Agid Y, Krack P, Broussolle E, Pollak P; French SPIDY-2 Study Group.

Lancet Neurol. 2009 Aug;8(8):709-17. doi: 10.1016/S1474-4422(09)70151-6. Epub 2009 Jul 1.

PMID:
19576854
46.

Reduced levodopa-induced complications after 5 years of subthalamic stimulation in Parkinson's disease: a second honeymoon.

Simonin C, Tir M, Devos D, Kreisler A, Dujardin K, Salleron J, Delval A, Blond S, Defebvre L, Destée A, Krystkowiak P.

J Neurol. 2009 Oct;256(10):1736-41. doi: 10.1007/s00415-009-5195-2. Epub 2009 Jun 18.

PMID:
19536584
47.

In vivo evidence for the selective subcortical degeneration in Huntington's disease.

Douaud G, Behrens TE, Poupon C, Cointepas Y, Jbabdi S, Gaura V, Golestani N, Krystkowiak P, Verny C, Damier P, Bachoud-Lévi AC, Hantraye P, Remy P.

Neuroimage. 2009 Jul 15;46(4):958-66. doi: 10.1016/j.neuroimage.2009.03.044. Epub 2009 Mar 28.

PMID:
19332141
48.

Neuroendocrine disturbances in Huntington's disease.

Saleh N, Moutereau S, Durr A, Krystkowiak P, Azulay JP, Tranchant C, Broussolle E, Morin F, Bachoud-Lévi AC, Maison P.

PLoS One. 2009;4(3):e4962. doi: 10.1371/journal.pone.0004962. Epub 2009 Mar 25.

49.

Myoclonus of peripheral origin: two case reports.

Tyvaert L, Krystkowiak P, Cassim F, Houdayer E, Kreisler A, Destée A, Defebvre L.

Mov Disord. 2009 Jan 30;24(2):274-7. doi: 10.1002/mds.21998.

PMID:
19086086
50.

Externally provoked freezing of gait in open runways in advanced Parkinson's disease results from motor and mental collapse.

Moreau C, Defebvre L, Bleuse S, Blatt JL, Duhamel A, Bloem BR, Destée A, Krystkowiak P.

J Neural Transm (Vienna). 2008 Oct;115(10):1431-6. doi: 10.1007/s00702-008-0099-3. Epub 2008 Aug 23.

PMID:
18726136

Supplemental Content

Loading ...
Support Center